利润表
FILANA THERAPEUTICS, INC.
FLNA
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | - | - | - | 41.12 | 10.89 | 11.48 |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
- | - | - | - | - | - | - | - | - | - | - | - | 41.12 | 10.89 | 11.48 |
|
营业费用
|
95.39 | 141.45 | 105.96 | 80.02 | 32.87 | 6.45 | 4.96 | 6.66 | 11.95 | 14.96 | 14.20 | 12.43 | 9.75 | 14.79 | 15.00 |
|
研发费用
|
26.59 | 69.64 | 89.42 | - | - | - | - | 2.97 | 7.62 | 9.18 | 9.10 | 7.31 | 4.92 | 7.61 | 8.30 |
|
销售、一般及行政费用
|
68.80 | 71.81 | 16.53 | 11.99 | 8.06 | 3.74 | 3.39 | 3.69 | 4.33 | 5.78 | 5.10 | 5.13 | 4.84 | 7.18 | 6.70 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-95.39 | -141.45 | -105.96 | -80.02 | -32.87 | -6.45 | -4.96 | -6.66 | -11.95 | -14.96 | -14.20 | -12.43 | 31.37 | -3.90 | -3.51 |
|
营业外收入
|
- | - | - | - | - | - | - | - | - | - | -0.06 | -0.05 | -0.11 | - | -0.90 |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
-0.20 | 0.41 | 0.91 | 1.00 | 0.43 | - | - | - | - | - | - | - | - | - | - |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | -14.15 | -12.39 | 31.47 | - | -2.61 |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | -0.07 | - | 0.00 |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-90.97 | -24.34 | -97.22 | -76.25 | -32.39 | 6.33 | -4.63 | -6.56 | -11.91 | -14.85 | -14.15 | -12.39 | 31.54 | -3.45 | -2.61 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-95.39 | -141.45 | -105.96 | -80.02 | -32.87 | -6.42 | -4.90 | -6.59 | -11.88 | -14.90 | -14.16 | -12.42 | 31.37 | -3.78 | -3.35 |
|
基本每股收益
|
-1.88 | -0.53 | -2.32 | - | - | - | - | - | - | - | -0.31 | -0.27 | 0.70 | - | - |
|
稀释每股收益
|
-1.88 | -1.46 | - | - | - | - | - | - | - | - | -0.31 | -0.27 | 0.70 | - | - |
|
加权平均股数
|
48.30 | 46.33 | 41.93 | - | - | - | - | - | - | - | 45.76 | 45.27 | 45.01 | - | - |
|
稀释加权平均股数
|
48.30 | 46.60 | - | - | - | - | - | - | - | - | 45.76 | 45.27 | 45.21 | - | - |
|
综合收益
|
- | - | - | - | - | - | - | - | -11.91 | -14.85 | -14.15 | -12.39 | 31.54 | -3.57 | -3.01 |